Divis Laboratories Ltd vs Mercury Laboratories Ltd

A side-by-side comparison of Divis Laboratories Ltd (DIVISLAB) and Mercury Laboratories Ltd (MERCURYLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divis Laboratories Ltd leads DIVISLAB vs MERCURYLAB on 11 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

75.78
P/E ratio
32.80
11.59
P/B ratio
1.77
0.41%
Dividend yield
0.41%
₹96.73
EPS
₹26.17

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
5.87%
22.00%
Return on capital
8.94%
33.00%
EBITDA margin
9.35%
24.32%
Net margin
4.18%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
0.27%
12.10%
Profit CAGR (3Y)
-3.72%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.93L Cr
Market cap
₹108 Cr
₹10,560 Cr
Revenue
₹75 Cr
₹2,568 Cr
Net profit
₹3 Cr
0.00
Debt / equity
0.14
Divis Laboratories Ltd
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 11.5 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
Mercury Laboratories Ltd
  • ["The company has delivered a poor sales growth of 2.05% over past five years.", "Company has a low return on equity of 8.84% over last 3 years."]
Divis Laboratories Ltd full analysis Mercury Laboratories Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.